Three biotechnology companies based in Ventura County recently received some good news from the U.S. Food and Drug Administration, gaining either approval or reviews for their treatments. These ...

Circio Holding ASA company and executive profile by Barron's. View the latest TA50 company infomation and executive bios.

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

A moratorium on artificial intelligence would weaken public oversight and freeze state protections at the very moment we need ...

After decades of failed attempts by corporate giants and research consortia across the globe, Kraig Biocraft Laboratories (OTCQB: KBLB) appears poised to crack biotechnology's most persistent ...

We've identified the following companies as similar to Capital Nasdaq Biotechnology Index Exchange Traded Fund because they operate in a related industry or sector. We also considered size, growth, ...

We've identified the following companies as similar to Global X Genomics & Biotechnology UCITS ETF USD Acc because they operate in a related industry or sector. We also considered size, growth, and ...

Frontiers, one of the world's largest and fastest growing open-access publishers, announces the launch of a new journal, Frontiers in Bioengineering and Biotechnology. A broad scope journal covering ...

In trading on Tuesday, biotechnology shares were relative laggards, down on the day by about 1.2%. Helping drag down the group were shares of Orchestra BioMed Holdings, down about 12.4% and shares of ...

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder, will ...

WASHINGTON, Jan 15 (Reuters) - The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related technology because of national security concerns ...

On Wednesday, Vir Biotechnology, Inc. (NASDAQ:VIR) presented initial Phase 1 data from two of its dual-masked T-cell engagers (TCEs): VIR-5818, which targets a variety of HER2-expressing solid tumors, ...